Kirby McInerney LLP announced an investigation into Hims & Hers Health, Inc. over potential securities fraud. The investigation concerns whether the company or its senior management violated federal securities laws or engaged in unlawful business practices. The probe follows a Federal Trade Commission lawsuit filed on July 29, 2026, accusing Hims of sharing customers' medical information with third-party advertisers, including Meta Platforms. On that news, Hims's stock price fell $4.32 per share, or 14.73%, to close at $25.00. No lawsuit has been filed yet, and the investigation is ongoing.
Hims Hers Health IncFTC lawsuit and securities fraud investigation over sharing medical info with advertisers
Meta Platforms Inc.